|
|
|
|
|
|
| |
| Meeting to Discuss Biosimilar Biologic User Fees |
| 12/07/2011 |
| |
|
ral Register Notice: FDA will hold a public meeting 12/16 to discuss the proposed recommendations for a user fee program for biosimilar biological products for fiscal years 2013 through 2017. The meeting will be held from 9 a.m. to 1 p.m. at FDA’s White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, Rm. 1503, Silver Spring, MD. Contact Rokhsana Safaai-Jazi, 796–4463. To view this notice, click here. |
| |
|
| |
| |
Any copying or electronic transfer without written permission is strictly prohibited and will result
in termination of service and prosecution under the federal Copyright Act.
To gain permission to copy this article log on to http://www.copyright.com.
|
|
RSS
